Today's Clinical Lab - News, Editorial and Products for the Clinical Laboratory

Accumen Releases First FDA EUA COVID-19 Saliva Testing Kits

COVID-19 saliva testing kits and testing implementation support available

COVID-19 Saliva Test Kit

The Spectrum saliva collection kit has been engineered to produce more accurate and sensitive test results, reduce sample collection errors, including for at-home self-collection, reduce labor required for collection, and reduce use of valuable PPE.

Accumen
Published:Aug 07, 2020
|2 min read
Register for free to listen to this article
Listen with Speechify
0:00
2:00

PHOENIX, AZ — July 31, 2020 — Accumen Inc. is helping health care get better, faster. Today the company announced a new partnership with medical equipment manufacturer, Spectrum Solutions, to provide COVID-19 saliva testing kits nationally.

“Accumen has been partnering with its clients to strengthen their laboratory supply chain for more than 10 years. Early in the COVID-19 crisis, we identified supply chain gaps and began coordinating resources to meet those evolving needs. As the crisis continued, we were able to provide critical testing supplies like nasopharyngeal (NP) swabs, media and personal protective equipment (PPE) for our clients, and we later made those resources available to other health systems and laboratories across the country to help increase testing efforts,” said Eric Jurinic, Accumen vice president of corporate supply chain. 

Saliva testing for detecting COVID-19 first received FDA Emergency Use Authorization (EUA) in April. This authorization mandated saliva collection solely using Spectrum’s SDNA-1000 saliva collection device based on a trial with Rutgers University. The Spectrum saliva collection kit has been engineered to produce more accurate and sensitive test results, reduce sample collection errors, including for at-home self-collection, reduce labor required for collection, and reduce use of valuable PPE. 

Additionally, the SDNA-1000 delivers 100 percent neutralization of the live virus mitigating risk and the threat of unnecessary exposure. It can also preserve and stabilize viral RNA transcripts for transport in extreme and varying temperatures for more than 14 days and for up to one-year post collection in ambient storage.

Accumen offers full kit or saliva collection device only orders, as well as implementation support services. Full details and order contact information are available here: https://accumen.com/resources/collateral/covid-saliva-collection-overview/.

Accumen continues to provide access to critical PPE for frontline workers produced by US-based manufacturers. The company’s COVID-19 Supply Chain Catalog with complete product details can be accessed at https://accumen.com/covid-19-resource-center/#supplychaincovidcatalog. Products include the aforementioned COVID-19 saliva testing kits, 3D-printed COVID-19 testing swabs, face shields and disposable masks, gowns, and gloves. 

For health care providers and institutions that need immediate access to other COVID-19-related resources, Accumen provides laboratory, imaging, blood management rapid response tools, and other strategic pandemic resources through its COVID-19 Resource Center at https://accumen.com/covid-19/#accumenresponsetools